SSTR2 and pituitary tumor: Low expression of β-arrestin 1, but not β-arrestin 2, in GH- and PRL-secreting pituitary tumors correlates with a reduced recycling rate of SSTR2 and better SS analogs response in terms of GH suppression, both in vitro and in vivo (67).